Cutera Inc Down 27.61% To $1.68 After Earnings Miss

Cutera Inc (CUTR) missed earnings estimates for Q4 2023 this afternoon.

Cutera Inc's earnings came in at an EPS loss of $1.36 per share, 45% lower than estimates for an EPS loss of $0.94 per share. The firm's loss per share expanded by 1260% since reporting a loss of $0.1 per share a year ago. Remember, earnings reported were on an adjusted basis, so they may not be comparable to prior reports and/or analyst estimates.

Consensus estimates for Cutera Inc revenue averaged out to $47.5 million, with the business managing to beat those expectations with reported fourth-quarter revenue of $49.5 million. The $2 million (4%) positive revenue surprise led to negative 26% growth year-over-year as the firm reported revenue of $67.4 million in its year-ago quarter. The lower earnings growth compared to revenue points to Cutera Inc not being able to improve its profit margin.

The stock is down 27.61% to $1.68 after the report.

The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.

Wall Street Analysts had an average rating of Hold on the stock prior to the report.

Trading in the five days leading up to the report earned Cutera Inc a Bullish Sentiment Rank from InvestorsObserver.

Prior to the report, InvestorsObserver gave the stock an overall score of 41. Meanwhile, the average Wall Street analyst rated the stock a Hold.

Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.